Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alexithymia and body image disturbances in women with Premenstrual Dysphoric Disorder.
De Berardis D, Campanella D, Gambi F, Sepede G, Carano A, Pelusi L, La Rovere R, Di Matteo D, Salini G, Cotellessa C, Salerno RM, Ferro FM. De Berardis D, et al. Among authors: di matteo d. J Psychosom Obstet Gynaecol. 2005 Dec;26(4):257-64. doi: 10.1080/01674820500109081. J Psychosom Obstet Gynaecol. 2005. PMID: 16457421 Free article.
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN.
Reis ES, Buonpane R, Celik H, Marty C, Lei A, Jobe F, Rupar M, Zhang Y, DiMatteo D, Awdew R, Ferreira BL, Leffet L, Lu L, Rosa E, Evrard M, Trivedi G, Wass B, Horsey A, He X, Covington M, Volgina A, Pasquier F, Legros L, Fouquet G, Vainchenker W, Yang YO, Barker B, Zhou J, Stewart S, Hitchcock IS, Dhanak D, Macarron R, Plo I, Nastri H, Mayes PA. Reis ES, et al. Blood. 2024 Nov 28;144(22):2336-2348. doi: 10.1182/blood.2024024373. Blood. 2024. PMID: 39255409 Free article.
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor.
Koblish HK, Wu L, Wang LS, Liu PCC, Wynn R, Rios-Doria J, Spitz S, Liu H, Volgina A, Zolotarjova N, Kapilashrami K, Behshad E, Covington M, Yang YO, Li J, Diamond S, Soloviev M, O'Hayer K, Rubin S, Kanellopoulou C, Yang G, Rupar M, DiMatteo D, Lin L, Stevens C, Zhang Y, Thekkat P, Geschwindt R, Marando C, Yeleswaram S, Jackson J, Scherle P, Huber R, Yao W, Hollis G. Koblish HK, et al. Cancer Discov. 2022 Jun 2;12(6):1482-1499. doi: 10.1158/2159-8290.CD-21-1156. Cancer Discov. 2022. PMID: 35254416 Free PMC article. Clinical Trial.
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models.
Liu PCC, Koblish H, Wu L, Bowman K, Diamond S, DiMatteo D, Zhang Y, Hansbury M, Rupar M, Wen X, Collier P, Feldman P, Klabe R, Burke KA, Soloviev M, Gardiner C, He X, Volgina A, Covington M, Ruggeri B, Wynn R, Burn TC, Scherle P, Yeleswaram S, Yao W, Huber R, Hollis G. Liu PCC, et al. PLoS One. 2020 Apr 21;15(4):e0231877. doi: 10.1371/journal.pone.0231877. eCollection 2020. PLoS One. 2020. PMID: 32315352 Free PMC article.
15 results